Bullish Outlook on Zura Bio Limited (ZURA) Amid Tibulizumab Phase 2 Clinical Trial Progress
The reaffirmed outlook came as Zura Bio Limited (NASDAQ:ZURA) reported its results for Q3 2025 on the same day.
Zura Bio Ltd (ZURA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Suvretta Capital Management Aaron Cowen | 9,067,001 | $53,948,656 | +63% | 1.38% |
| 2. | Great Point Partners Jeffrey Jay And David Kroin | 4,215,930 | $25,084,784 | +11% | 5.77% |
| 3. | Braidwell LP Alex Karnal | 3,988,989 | $23,734,485 | +26% | 0.79% |
| 4. | Siren L.L.C. Raymond Debbane | 3,734,866 | $22,222,453 | +188% | 0.62% |
| 5. | Commodore Capital Egen Atkinson And Michael Kramarz | 3,250,000 | $19,337,500 | 1.12% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.25 | 2,000,000 | $12,500,000.00 | 6,552,725 | 2026-02-26 | Filing | |
| $6.20 | 80,000 | $496,000.00 | 100,000 | 2024-05-17 | Filing | |
| $3.13 | 7,987 | $24,999.31 | 7,987 | 2024-04-22 | Filing | |
| $3.13 | 3,195 | $10,000.35 | 3,195 | 2024-04-22 | Filing | |
| $3.13 | 159,744 | $499,998.72 | 777,384 | 2024-04-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.73 | 1,001,633 | $2,734,458.09 | 0 | 2024-11-25 | Filing | |
| $2.70 | 3,800,000 | $10,260,000.00 | 1,001,633 | 2024-09-11 | Filing | |
| $3.87 | 51,728 | $200,187.36 | 2,085,418 | 2024-09-04 | Filing | |
| $4.00 | 2,000,000 | $8,000,000.00 | 4,801,633 | 2023-12-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,434,990 | $38,288,191 | 1.43% | |
| 2. | 4,458,851 | $25,326,274 | 0% | |
| 3. | 2,838,913 | $16,834,754 | 7.05% | |
| 4. | 2,564,303 | $15,257,603 | 0.79% | |
| 5. | 872,950 | $5,194,053 | 0% |
News See All
12 Hot Penny Stocks to Invest in Right Now
Goldman Sachs Asset Management portfolio manager Greg Tuorto appeared on CNBC on November 17, 2025.
13 Penny Stocks with Insider Buying in 2024
In this article, we will take a detailed look at the 13 Penny Stocks with Insider Buying in 2024. If you want to skip our detailed analysis and see the top 5 stocks in this list, click 5 Penny Stocks...
Hedge Fund Resource Center